3-(2-boronoethyl)-6-(1-carbamimidoylazetidin-3-yl)oxy-2-hydroxybenzoic acid
C13H18BN3O6 — CID 142513905
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(2-boronoethyl)-6-(1-carbamimidoylazetidin-3-yl)oxy-2-hydroxybenzoic acid
3-(2-boronoethyl)-6-(1-carbamimidoylazetidin-3-yl)oxy-2-hydroxybenzoic acid (PubChem CID 142513905) has the molecular formula C13H18BN3O6 and a molecular weight of 323.11 g/mol. Its IUPAC name is 3-(2-boronoethyl)-6-(1-carbamimidoylazetidin-3-yl)oxy-2-hydroxybenzoic acid.
Molecular Properties
| Compound Name | 3-(2-boronoethyl)-6-(1-carbamimidoylazetidin-3-yl)oxy-2-hydroxybenzoic acid |
|---|---|
| PubChem CID | 142513905 |
| Molecular Formula | C13H18BN3O6 |
| Molecular Weight | 323.11 g/mol |
| Exact Mass | 323.13 |
| IUPAC Name | 3-(2-boronoethyl)-6-(1-carbamimidoylazetidin-3-yl)oxy-2-hydroxybenzoic acid |
| SMILES | [H]/N=C(\N)N1CC(Oc2ccc(CCB(O)O)c(O)c2C(=O)O)C1 |
| InChI | InChI=1S/C13H18BN3O6/c15-13(16)17-5-8(6-17)23-9-2-1-7(3-4-14(21)22)11(18)10(9)12(19)20/h1-2,8,18,21-22H,3-6H2,(H3,15,16)(H,19,20) |
| InChIKey | KMMPBHQCUIFERN-UHFFFAOYSA-N |
| XLogP | -0.94 |
| TPSA | 160.33 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 323.11 |
| LogP ≤ 5 | -0.94 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142513905 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.